Pacer Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Sell |
46,378
-1,210,835
| -96% | -$432M | 0.05% | 348 |
|
|
2025
Q4 | $411M | Sell |
1,257,213
-355,908
| -22% | -$113M | 1.05% | 16 |
|
|
2025
Q3 | $455M | Sell |
1,613,121
-105,180
| -6% | -$30.5M | 1.15% | 8 |
|
|
2025
Q2 | $480M | Buy |
1,718,301
+140,550
| +9% | +$39.8M | 1.19% | 8 |
|
|
2025
Q1 | $492M | Buy |
1,577,751
+1,489,446
| +1,687% | +$440M | 1.15% | 18 |
|
|
2024
Q4 | $23M | Buy |
88,305
+20,962
| +31% | +$6.22M | 0.05% | 307 |
|
|
2024
Q3 | $21.7M | Sell |
67,343
-6,696
| -9% | -$2.19M | 0.05% | 319 |
|
|
2024
Q2 | $23.1M | Buy |
74,039
+6,048
| +9% | +$1.78M | 0.05% | 301 |
|
|
2024
Q1 | $19.3M | Sell |
67,991
-5,524
| -8% | -$1.62M | 0.04% | 325 |
|
|
2023
Q4 | $21.2M | Sell |
73,515
-124,123
| -63% | -$33.8M | 0.06% | 288 |
|
|
2023
Q3 | $53.1M | Buy |
197,638
+17,991
| +10% | +$4.49M | 0.2% | 123 |
|
|
2023
Q2 | $39.9M | Buy |
179,647
+110,226
| +159% | +$25.6M | 0.16% | 137 |
|
|
2023
Q1 | $16.8M | Buy |
69,421
+11,885
| +21% | +$2.92M | 0.07% | 269 |
|
|
2022
Q4 | $15.1M | Buy |
57,536
+37,730
| +190% | +$10.1M | 0.08% | 206 |
|
|
2022
Q3 | $4.46M | Sell |
19,806
-31,783
| -62% | -$7.7M | 0.03% | 363 |
|
|
2022
Q2 | $12.6M | Sell |
51,589
-1,267
| -2% | -$310K | 0.09% | 183 |
|
|
2022
Q1 | $12.8M | Sell |
52,856
-7,150
| -12% | -$1.64M | 0.1% | 190 |
|
|
2021
Q4 | $13.5M | Sell |
60,006
-3,175
| -5% | -$670K | 0.14% | 137 |
|
|
2021
Q3 | $13.4M | Sell |
63,181
-161
| -0.3% | -$37.1K | 0.17% | 85 |
|
|
2021
Q2 | $15.4M | Buy |
63,342
+12,322
| +24% | +$3.03M | 0.22% | 65 |
|
|
2021
Q1 | $12.7M | Sell |
51,020
-3,590
| -7% | -$857K | 0.22% | 62 |
|
|
2020
Q4 | $12.6M | Sell |
54,610
-30,240
| -36% | -$6.97M | 0.24% | 61 |
|
|
2020
Q3 | $21.6M | Sell |
84,850
-12,869
| -13% | -$3.19M | 0.46% | 34 |
|
|
2020
Q2 | $23M | Buy |
97,719
+49,502
| +103% | +$11.3M | 0.47% | 39 |
|
|
2020
Q1 | $11.3M | Buy |
48,217
+1,410
| +3% | +$308K | 0.23% | 37 |
|
|
2019
Q4 | $11.3M | Sell |
46,807
-82,858
| -64% | -$18.3M | 0.51% | 23 |
|
|
2019
Q3 | $25.1M | Buy |
129,665
+2,136
| +2% | +$410K | 0.56% | 25 |
|
|
2019
Q2 | $23.5M | Buy |
127,529
+11,134
| +10% | +$1.99M | 0.57% | 24 |
|
|
2019
Q1 | $22.1M | Buy |
116,395
+98,479
| +550% | +$18.8M | 0.61% | 22 |
|
|
2018
Q4 | $3.49M | Sell |
17,916
-58,586
| -77% | -$11.4M | 0.12% | 24 |
|
|
2018
Q3 | $15.9M | Buy |
76,502
+19,366
| +34% | +$3.82M | 0.6% | 19 |
|
|
2018
Q2 | $10.5M | Buy |
57,136
+9,666
| +20% | +$1.71M | 0.48% | 26 |
|
|
2018
Q1 | $8.09M | Buy |
47,470
+6,245
| +15% | +$1.15M | 0.45% | 33 |
|
|
2017
Q4 | $7.17M | Buy |
41,225
+12,660
| +44% | +$2.24M | 0.5% | 25 |
|
|
2017
Q3 | $5.33M | Buy |
28,565
+3,187
| +13% | +$565K | 0.47% | 26 |
|
|
2017
Q2 | $4.37M | Buy |
25,378
+2,362
| +10% | +$384K | 0.43% | 27 |
|
|
2017
Q1 | $3.78M | Buy |
23,016
+1,782
| +8% | +$296K | 0.46% | 29 |
|
|
2016
Q4 | $3.1M | Sell |
21,234
-420
| -2% | -$63.2K | 0.44% | 30 |
|
|
2016
Q3 | $3.61M | Sell |
21,654
-577
| -3% | -$97.6K | 0.55% | 24 |
|
|
2016
Q2 | $3.38M | Buy |
22,231
+36
| +0.2% | +$5.6K | 0.53% | 24 |
|
|
2016
Q1 | $3.33M | Buy |
22,195
+509
| +2% | +$75.6K | 0.76% | 23 |
|
|
2015
Q4 | $3.52M | Buy |
+21,686
| New | +$3.41M | 0.83% | 19 |
|
|
2013
Q4 | $437K | Buy |
+2,742
| New | +$312K | 0.11% | 247 |
|
Other funds holding AMGN
VCM
VPM
Pacer Advisors's AMGN Position: Q1 2026 in Review
Pacer Advisors reduced its Amgen (AMGN) stake by 96% in Q1 2026, selling an estimated $432M and leaving 46,378 shares worth $16.3M. The position accounts for 0.05% of the portfolio, ranked #348.
Pacer Advisors first reported a position in AMGN in Q4 2013 and has held it in 43 quarters since. The position peaked at $492M in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Pacer Advisors held 46,378 shares of Amgen worth $16.3M as of Q1 2026.
- Pacer Advisors sold 1,210,835 Amgen shares in Q1 2026, an estimated $432M.
- Amgen made up 0.05% of Pacer Advisors's portfolio in Q1 2026, its #348 holding.
- Pacer Advisors first reported a position in Amgen in Q4 2013 and has held it in 43 quarters since.
- Pacer Advisors's Amgen position peaked at $492M in Q1 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.